Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.02B |
| 2 |
Apple
AAPL
|
+$837M |
| 3 |
Amazon
AMZN
|
+$811M |
| 4 |
Kenvue
KVUE
|
+$761M |
| 5 |
Blackstone
BX
|
+$581M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$438M |
| 2 |
Texas Instruments
TXN
|
+$235M |
| 3 |
Pfizer
PFE
|
+$205M |
| 4 |
LSI
Life Storage, Inc.
LSI
|
+$202M |
| 5 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.7% |
| 2 | Healthcare | 13.07% |
| 3 | Financials | 12.46% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Genelux
GNLX
$126M
| $9.47M | ﹤0.01% |
386,634
+321,596
| +494% | +$8.15M |
|
|
VZIO
2302
DELISTED
VIZIO Holding Corp.
VZIO
| $9.45M | ﹤0.01% |
1,746,103
+476,107
| +37% | +$3.06M |
|
2303
4D Molecular Therapeutics
FDMT
$536M
| $9.44M | ﹤0.01% |
741,665
+51,888
| +8% | +$868K |
|
|
INST
2304
DELISTED
Instructure Holdings, Inc.
INST
| $9.44M | ﹤0.01% |
371,574
+26,334
| +8% | +$682K |
|
2305
CEVA Inc
CEVA
$1.01B
| $9.43M | ﹤0.01% |
486,502
+16,290
| +3% | +$378K |
|
2306
Midland States Bancorp
MSBI
$717M
| $9.42M | ﹤0.01% |
458,389
+18,599
| +4% | +$409K |
|
2307
Planet Labs
PL
$8.14B
| $9.4M | ﹤0.01% |
3,615,919
-93,110
| -3% | -$296K |
|
2308
Amerant Bancorp
AMTB
$1.16B
| $9.39M | ﹤0.01% |
538,281
+6,816
| +1% | +$130K |
|
|
ALX
2309
Alexander's
ALX
$1.4B
| $9.38M | ﹤0.01% |
51,465
+2,982
| +6% | +$563K |
|
2310
Tarsus Pharmaceuticals
TARS
$2.67B
| $9.35M | ﹤0.01% |
526,260
+81,399
| +18% | +$1.44M |
|
2311
Compañía de Minas Buenaventura
BVN
$8.19B
| $9.34M | ﹤0.01% |
1,101,985
+61,703
| +6% | +$495K |
|
2312
Vishay Precision Group
VPG
$1.34B
| $9.32M | ﹤0.01% |
277,654
+10,863
| +4% | +$387K |
|
2313
Aspen Aerogels
ASPN
$419M
| $9.25M | ﹤0.01% |
1,075,276
+8,591
| +0.8% | +$61K |
|
|
CFB
2314
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $9.24M | ﹤0.01% |
915,900
+32,307
| +4% | +$352K |
|
2315
FLEX LNG
FLNG
$1.65B
| $9.24M | ﹤0.01% |
306,238
+16,584
| +6% | +$512K |
|
|
SHOE
2316
Shoe Station Group
SHOE
$422M
| $9.23M | ﹤0.01% |
384,221
+34,837
| +10% | +$827K |
|
|
TRTX
2317
TPG RE Finance Trust
TRTX
$614M
| $9.22M | ﹤0.01% |
1,370,544
+45,120
| +3% | +$327K |
|
2318
Central Pacific Financial
CPF
$1.03B
| $9.22M | ﹤0.01% |
552,410
+17,103
| +3% | +$292K |
|
2319
The RMR Group
RMR
$325M
| $9.2M | ﹤0.01% |
375,195
+38,706
| +12% | +$933K |
|
2320
DocGo
DCGO
$64.4M
| $9.2M | ﹤0.01% |
1,725,087
+78,765
| +5% | +$639K |
|
|
TBI
2321
Trueblue
TBI
$234M
| $9.18M | ﹤0.01% |
625,407
+20,781
| +3% | +$324K |
|
2322
Aclaris Therapeutics
ACRS
$835M
| $9.16M | ﹤0.01% |
1,337,082
+99,673
| +8% | +$852K |
|
|
RNAM
2323
DELISTED
Avidity Biosciences
RNAM
| $9.16M | ﹤0.01% |
1,435,553
-2,997
| -0.2% | -$25.8K |
|
2324
Theravance Biopharma
TBPH
$875M
| $9.16M | ﹤0.01% |
1,061,177
-104,485
| -9% | -$1.01M |
|
2325
Kearny Financial
KRNY
$613M
| $9.16M | ﹤0.01% |
1,321,084
+56,302
| +4% | +$427K |
|
Similar funds
Geode Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Geode Capital Management held 4,905 positions worth $840B, down 1.3% from $851B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Geode Capital Management's Q3 2023 filing shows 147 new, 3,717 increased, 626 reduced and 142 closed positions. Its largest new stake was Kenvue: 32,873,626 shares worth $659M. The largest sale was Johnson & Johnson, an estimated $438M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q3 2023 buy was Kenvue: 32,873,626 shares worth $659M.
- Geode Capital Management added most to Microsoft in Q3 2023, an estimated $1.02B increase.
- Geode Capital Management's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $438M.
- Geode Capital Management fully exited Life Storage, Inc. in Q3 2023, selling an estimated $202M.
- Geode Capital Management's ten largest holdings make up 26% of its $840B portfolio in Q3 2023.
- Geode Capital Management opened 147 new positions and closed 142 in Q3 2023.
- Geode Capital Management's portfolio value fell 1.3% quarter-over-quarter to $840B.
Based on Geode Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.